Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 26
Filter
2.
Am J Otolaryngol ; 43(3): 103438, 2022.
Article in English | MEDLINE | ID: mdl-35489110

ABSTRACT

PURPOSE: To evaluate the impact of hospital safety-net burden and social demographics on the overall survival of patients with oral cavity squamous cell carcinoma. MATERIALS AND METHODS: We identified 48,176 oral cancer patients diagnosed between the years 2004 to 2015 from the National Cancer Database and categorized treatment facilities as no, low, or high safety-net burden hospitals based on the percentage of uninsured or Medicaid patients treated. Using the Kaplan Meier method and multivariate analysis, we examined the effect of hospital safety-net burden, sociodemographic variables, and clinical factors on overall survival. RESULTS: Of the 1269 treatment facilities assessed, the median percentage of uninsured/Medicaid patients treated was 0% at no, 11.6% at low, and 23.5% at high safety-net burden hospitals and median survival was 68.6, 74.8, and 55.0 months, respectively (p < 0.0001). High safety-net burden hospitals treated more non-white populations (15.4%), lower median household income (<$30,000) (23.2%), and advanced stage cancers (AJCC III/IV) (54.6%). Patients treated at low (aHR = 0.97; 95% CI = 0.91-1.04, p = 0.405) and high (aHR = 1.05; 95% CI = 0.98-1.13, p = 0.175) safety-net burden hospitals did not experience worse survival outcomes compared to patients treated at no safety-net burden hospitals. CONCLUSION: High safety-net burden hospitals treated more oral cancer patients of lower socioeconomic status and advanced disease. Multivariate analysis showed high safety-net burden hospitals achieved comparable patient survival to lower burden hospitals.


Subject(s)
Mouth Neoplasms , Safety-net Providers , Hospitals , Humans , Medicaid , Medically Uninsured , Mouth Neoplasms/therapy , United States/epidemiology
3.
Ann Otol Rhinol Laryngol ; 131(8): 844-850, 2022 Aug.
Article in English | MEDLINE | ID: mdl-34521247

ABSTRACT

OBJECTIVE: This study aims to identify clinical and socioeconomic factors associated with long-term, post-surgical opioid use in the head and neck cancer population. METHODS: A single center retrospective study was conducted including patients diagnosed with head and neck cancer between January 1, 2014 and July 1, 2019 who underwent primary surgical management. The primary outcome measure was continued opioid use 6 months after treatment completion. Both demographic and cancer-related variables were recorded to determine what factors were associated with prolonged opioid use. Univariate analysis was performed using chi-squared test for categorical variables and 2-sample t-test for continuous variables. Multivariate analysis was performed using logistic regression. RESULTS: A total of 359 patients received primary surgical management. Forty-five patients (12.53%) continued to take opioids 6 months after treatment completion. Using univariate analysis, patients less than 65 years of age (P = .0126), adjuvant chemoradiation (n = 25, P < .001), and overall length of hospital stay (8.60 ± 8.58 days, P = .0274) were significantly associated with long term opioid use. Multivariate logistic regression showed that adjuvant chemoradiation (OR = 3.446, 95% CI [1.742, 6.820], P = .0004) and overall length of hospital stay (OR = 0.949, 95% CI [0.903, 0.997], P = .0373) to be significantly associated with opioid use 6 months after head and neck cancer treatment. CONCLUSION: Long-term postoperative opioid use in head and neck cancer patients is significantly associated with adjuvant chemoradiation, and patients with longer length of hospital stay. Therefore, future research should focus on interventions to better manage opioid use during the acute treatment period to decrease long-term use.


Subject(s)
Head and Neck Neoplasms , Opioid-Related Disorders , Analgesics, Opioid/therapeutic use , Head and Neck Neoplasms/drug therapy , Head and Neck Neoplasms/surgery , Humans , Length of Stay , Opioid-Related Disorders/epidemiology , Pain, Postoperative/drug therapy , Pain, Postoperative/etiology , Retrospective Studies
4.
Laryngoscope ; 132(5): 1022-1028, 2022 05.
Article in English | MEDLINE | ID: mdl-34762300

ABSTRACT

OBJECTIVES/HYPOTHESIS: Follow-up care in head and neck cancers (HNC) is critical in managing patient health. However, social determinants of health (SDOH) can create difficulties in maintaining follow-up care. The study goal is to explore how SDOH impacts maintenance of HNC follow-up care appointments. METHODS: A systematic retrospective chart review of 877 HNC patients diagnosed in the past 10 years a safety-net tertiary care hospital with systems to help reduce care disparities. Cohort groups were identified and compared against protocols for follow-up. Data were analyzed using analysis of variance, chi-square tests, Fisher's exact tests, two-sample t-tests, and simple linear regression. RESULTS: The average length of follow-up time in months and average total number of follow-ups over 5 years were 32.96 (34.60) and 9.24 (7.87), respectively. There was no significant difference in follow-up care between United States (US) versus non-US born and English versus non-English speaking patients. Race/ethnicity, county median household income, insurance status, and county educational attainment were not associated with differences in follow-up. However, living a greater distance from the hospital was associated with lower follow-up length and less frequency in follow-up (P < .0001). CONCLUSION: While income, primary language, country of birth, race/ethnicity, insurance status, and markers of educational attainment do not appear to impact HNC follow-up at our safety-net, tertiary care institution, and distance from hospital remains an important contributor to disparities in care. This study shows that many barriers to care can be addressed in a model that addresses SDOH, but there are barriers that still require additional systems and resources. Laryngoscope, 132:1022-1028, 2022.


Subject(s)
Aftercare , Head and Neck Neoplasms , Head and Neck Neoplasms/therapy , Humans , Insurance Coverage , Retrospective Studies , Social Determinants of Health , United States
5.
Head Neck ; 44(2): 372-381, 2022 02.
Article in English | MEDLINE | ID: mdl-34889486

ABSTRACT

BACKGROUND: This study compares select social determinants of health (SDOH) with treatment modality selection and treatment completion in head and neck cancer (HNC) patients, to better understand disparities in health outcomes. METHODS: A retrospective cohort study of HNC (n = 1428) patients was conducted. Demographic and disease-specific variables were recorded, including treatment modality selection and completion. Data were analyzed using two-sample t tests, chi-square, and Fisher's exact tests. RESULTS: Primary language was significantly associated with treatment choice, where non-English speakers were less likely to choose treatment as recommended by the Tumor Board. Lower mean distance from the hospital (37.38 [48.31] vs. 16.92 [19.10], p < 0.0001) and a county-based higher mean percentage of bachelor degree or higher education (42.16 [8.82] vs. 44.95 [6.19], p < 0.0003) were associated with treatment selection. CONCLUSION: Language, distance from the hospital, and education affected treatment selection in this study and may be useful in understanding how to counsel patients on treatment selection for HNC.


Subject(s)
Head and Neck Neoplasms , Social Determinants of Health , Head and Neck Neoplasms/therapy , Humans , Retrospective Studies , Surveys and Questionnaires
6.
J Dent Educ ; 85(2): 176-186, 2021 Feb.
Article in English | MEDLINE | ID: mdl-32965685

ABSTRACT

OBJECTIVES: This study assesses the levels of grit (the perseverance and passion for long-term goals), and resilience (the ability to bounce back or recover from stress), reported by U.S. dental students, and its possible association with academic achievements. METHODS: An anonymous 27 question cross-sectional online survey with sections on demographics, grit, resilience, and academic achievement was e-mailed to all dental students in the U.S. The Short Grit and Brief Resilience scales were used. Scores for both scales ranged from 1 to 5, and were grouped into low, moderate, and high tertiles based on distribution. Dental school grade point average (GPA), and class rank were used to measure academic achievement, and were similarly grouped. Odds ratios (ORs) and 95% confidence intervals (CIs) were obtained from multinomial logistic regression models assessing the relationship of grit and resilience to the outcomes adjusting for gender, dental school year, race, geographic origin, and a variable combining education and income. RESULTS: Of the 3292 (17%) respondents, 58% were female. Hispanics reported significantly higher grit and resilience scores while Asian students reported the lowest. 18% of Hispanics were ranked in the top 20 percentile versus 37% of whites. CONCLUSION: Results indicate that dental students with high grit (high vs. low scores: OR [95% CI]: 2.06 [1.57-2.72]) and resilience (high vs. low scores: 1.36 [1.04-1.76]) achieved higher GPA and better class ranks. Therefore, it is crucial for students wanting to achieve academic success to consider the value that these non-cognitive characteristics might have on their overall progress.


Subject(s)
Academic Success , Cross-Sectional Studies , Female , Humans , Male , Students, Dental
7.
Ear Nose Throat J ; 100(2): NP62-NP68, 2021 Feb.
Article in English | MEDLINE | ID: mdl-31170822

ABSTRACT

OBJECTIVE: To determine whether surgical case volume is a predictive factor of surgical outcomes when managing geriatric patients with head andneck cancer. METHODS: A cross-sectional study design was used. Data were obtainedfrom the Vizient Database, which included a total of 93 academicinstitutions. Men and women aged between 65 and 100 years undergoing head and neck cancer surgery during 2009 and 2012,excluding cases of thyroid cancer and skin cancer of the head and neck(n = 4544) were included in the study. Hospital case volume was definedas low (≤21 cases/year), moderate (22-49 cases/year), or high (≥50 cases/year). The frequency of comorbidities and complications wasmeasured by hospital case volume using a χ2 test. Significancewas determined with an α level of .05. RESULTS: The largest number of head and neck cancer cases involving comorbidities (90.54%) and the highest rate of overall complications(27.50%) occurred in moderate case volume institutions compared to athe complication rate of 22.89% in low volume hospitals and 21.50% in highvolume hospitals (P < .0001). The most common comorbidities across all3 hospital case volumes included hypertension, metastatic cancer,and chronic pulmonary disease and the most common complicationsincluded hemorrhage/hematoma and postoperative pulmonarycompromise. CONCLUSION: With more geriatric patients requiring surgery for head andneck cancer, it would be beneficial to manage the more complex cases at high volume centers and to develop multidisciplinary teams to optimizecase management and minimize complications.


Subject(s)
Head and Neck Neoplasms/surgery , Hospitals, High-Volume/statistics & numerical data , Hospitals, Low-Volume/statistics & numerical data , Otorhinolaryngologic Surgical Procedures/statistics & numerical data , Postoperative Complications/epidemiology , Aged , Aged, 80 and over , Comorbidity , Cross-Sectional Studies , Databases, Factual , Female , Humans , Male , Otorhinolaryngologic Surgical Procedures/adverse effects , Postoperative Complications/etiology , United States/epidemiology
8.
Eur J Radiol ; 132: 109259, 2020 Nov.
Article in English | MEDLINE | ID: mdl-33012550

ABSTRACT

PURPOSE: Osteoradionecrosis (ORN) is a serious complication after radiotherapy (RT), even in the era of intensity modulated radiation therapy (IMRT). The purpose of this study was to evaluate whether 18F-FDG PET/CT can predict ORN associated with periodontal disease in patients with oropharyngeal or oral cavity squamous cell carcinoma (OP/OC SCC) undergoing RT. METHODS: One hundred and five OP/OC SCC patients treated with RT who underwent pretreatment 18F-FDG PET/CT between October 2007 and June 2016 were retrospectively reviewed. A post-treatment diagnosis of ORN was made clinically based on presence of exposed irradiated mandibular bone that failed to heal after a period of three months without persistent or recurrent tumor. The maximum standardized uptake value (SUVmax) of periodontal regions identified on PET/CT was measured for all patients. Image-based staging of periodontitis was also performed using American Academy of Periodontology staging system on CT. RESULTS: Among 105 patients, 14 (13.3 %) developed ORN. The SUVmax of the periodontal region in patients with ORN (3.35 ±â€¯1.23) was significantly higher than patients without ORN (1.92 ±â€¯0.66) (P <  .01). The corresponding CT stage of periodontitis in patients with ORN was significantly higher (2.71±0.47) than patients without ORN (1.80±0.73) (P <  .01). ROC analysis revealed the cut-off values of developing ORN were 2.1 in SUVmax, and II in CT stage of periodontitis. The corresponding AUC was 0.86 and 0.82, respectively. CONCLUSIONS: Pretreatment 18F-FDG PET/CT identification of periodontitis may be helpful to predict the future development of ORN in patients with OP/OC SCC undergoing RT.


Subject(s)
Head and Neck Neoplasms , Osteoradionecrosis , Periodontitis , Fluorodeoxyglucose F18 , Humans , Neoplasm Recurrence, Local , Osteoradionecrosis/diagnostic imaging , Osteoradionecrosis/etiology , Periodontitis/diagnostic imaging , Positron Emission Tomography Computed Tomography , Radiopharmaceuticals , Retrospective Studies , Risk Assessment
9.
Eur Radiol ; 30(11): 6322-6330, 2020 Nov.
Article in English | MEDLINE | ID: mdl-32524219

ABSTRACT

OBJECTIVE: To assess the utility of deep learning analysis using 18F-fluorodeoxyglucose (FDG) uptake by positron emission tomography (PET/CT) to predict disease-free survival (DFS) in patients with oral cavity squamous cell carcinoma (OCSCC). METHODS: One hundred thirteen patients with OCSCC who received pretreatment FDG-PET/CT were included. They were divided into training (83 patients) and test (30 patients) sets. The diagnosis of treatment control/failure and the DFS rate were obtained from patients' medical records. In deep learning analyses, three planes of axial, coronal, and sagittal FDG-PET images were assessed by ResNet-101 architecture. In the training set, image analysis was performed for the diagnostic model creation. The test data set was subsequently analyzed for confirmation of diagnostic accuracy. T-stage, clinical stage, and conventional FDG-PET parameters (the maximum and mean standardized uptake value (SUVmax and SUVmean), heterogeneity index, metabolic tumor volume (MTV), and total lesion glycolysis (TLG) were also assessed with determining the optimal cutoff from training dataset and then validated their diagnostic ability from test dataset. RESULTS: In dividing into patients with treatment control and failure, the highest diagnostic accuracy of 0.8 was obtained using deep learning classification, with a sensitivity of 0.8, specificity of 0.8, positive predictive value of 0.89, and negative predictive value of 0.67. In the Kaplan-Meier analysis, the DFS rate was significantly different only with the analysis of deep learning-based classification (p < .01). CONCLUSIONS: Deep learning-based diagnosis with FDG-PET images may predict treatment outcome in patients with OCSCC. KEY POINTS: • Deep learning-based diagnosis of FDG-PET images showed the highest diagnostic accuracy to predict the treatment outcome in patients with oral cavity squamous cell carcinoma. • Deep learning-based diagnosis was shown to differentiate patients between good and poor disease-free survival more clearly than conventional T-stage, clinical stage, and conventional FDG-PET-based parameters.


Subject(s)
Deep Learning , Diagnosis, Computer-Assisted/methods , Mouth Neoplasms/diagnostic imaging , Positron Emission Tomography Computed Tomography , Squamous Cell Carcinoma of Head and Neck/diagnostic imaging , Adult , Aged , Aged, 80 and over , Algorithms , Disease-Free Survival , Female , Fluorodeoxyglucose F18 , Glycolysis , Humans , Kaplan-Meier Estimate , Male , Middle Aged , Mouth Neoplasms/pathology , Neoplasm Staging , Predictive Value of Tests , Reproducibility of Results , Retrospective Studies , Sensitivity and Specificity , Squamous Cell Carcinoma of Head and Neck/pathology , Treatment Outcome , Tumor Burden
10.
Eur J Radiol ; 120: 108654, 2019 Nov.
Article in English | MEDLINE | ID: mdl-31539792

ABSTRACT

PURPOSE: Cystic and cystic-appearing odontogenic lesions of the jaw may appear similar on CT imaging. Accurate diagnosis is often difficult although the relationship of the lesion to the tooth root or crown may offer a clue to the etiology. The purpose of this study was to evaluate CT texture analysis as an aid in differentiating cystic and cystic-appearing odontogenic lesions of the jaw. METHODS: This was an IRB-approved retrospective study including 42 pathology-proven dentigerous cysts, 37 odontogenic keratocysts, and 19 ameloblastomas. Each lesion was manually segmented on axial CT images, and textural features were analyzed using an in-house-developed Matlab-based texture analysis program that extracted 47 texture features from each segmented volume. Statistical analysis was performed comparing all pairs of the three types of lesions. RESULTS: Pairwise analysis revealed that nine histogram features, one GLCM feature, three GLRL features, two Laws features, four GLGM features and two Chi-square features showed significant differences between dentigerous cysts and odontogenic keratocysts. Four histogram features and one Chi-square feature showed significant differences between odontogenic keratocysts and ameloblastomas. Two histogram features showed significant differences between dentigerous cysts and ameloblastomas. CONCLUSIONS: CT texture analysis may be useful as a noninvasive method to obtain additional quantitative information to differentiate cystic and cystic-appearing odontogenic lesions of the jaw.


Subject(s)
Ameloblastoma/diagnostic imaging , Jaw Neoplasms/diagnostic imaging , Odontogenic Cysts/diagnostic imaging , Adolescent , Adult , Aged , Aged, 80 and over , Ameloblastoma/pathology , Child , Dentigerous Cyst/diagnostic imaging , Dentigerous Cyst/pathology , Diagnosis, Differential , Female , Humans , Jaw Neoplasms/pathology , Male , Middle Aged , Odontogenic Cysts/pathology , Retrospective Studies , Tomography, X-Ray Computed/methods , Young Adult
12.
Head Neck ; 41(9): 2976-2982, 2019 09.
Article in English | MEDLINE | ID: mdl-31025799

ABSTRACT

BACKGROUND: To evaluate recategorization of pT1-3N0 oral tongue cancer, from seventh to eighth editions of the American Joint Committee on Cancer (AJCC) staging classification, and impact on overall survival (OS). METHODS: Using the National Cancer Database, 1277 patients were categorized using tumor size and depth of invasion with seventh and eighth AJCC staging systems and evaluated for OS. RESULTS: Tumor-category was unchanged in 82.9% and upstaged in 17.1% patients with eighth AJCC. The 3-year OS was 85.3%, 76.6%, and 77.0% with seventh AJCC compared to 87.1%, 75.1%, and 81% with eighth AJCC, for patients with pT1N0, pT2N0, and pT3N0 disease, respectively. Improved discrimination of pT1N0 vs pT2N0 for OS on multivariate analysis was seen for eighth AJCC (hazard ratio [HR] = 1.43, 95% confidence interval [CI]: 1.03-1.98, P = .03) but not for patients with pT3N0, with seventh AJCC (HR = 1.02, 95% CI:0.53-1.98, P = .95), and eighth AJCC (HR = 0.86, 95% CI: 0.52-1.42, P = .55). CONCLUSION: Eighth edition AJCC staging leads to improved discrimination of OS between pT1N0 and pT2N0 but not for patients with pT3N0.


Subject(s)
Carcinoma, Squamous Cell/pathology , Neoplasm Staging/standards , Tongue Neoplasms/pathology , Aged , Carcinoma, Squamous Cell/mortality , Databases, Factual , Female , Humans , Male , Middle Aged , Retrospective Studies , Survival Analysis , Tongue Neoplasms/mortality , United States/epidemiology
13.
Otolaryngol Head Neck Surg ; 160(1): 77-84, 2019 01.
Article in English | MEDLINE | ID: mdl-29944460

ABSTRACT

OBJECTIVE: To determine if adjuvant radiation therapy for patients with pT2N0 oral cavity tongue cancer affects overall survival. STUDY DESIGN: Retrospective cohort study. SETTING: National Cancer Database. SUBJECTS AND METHODS: Cases diagnosed between 2004 and 2013 with pathologic stage pT2N0 oral cavity tongue cancer with negative surgical margins were extracted from the National Cancer Database. Data were stratified by treatment received, including surgery only and surgery + postoperative radiation therapy. Univariate analysis was performed with a 2-sample t test, chi-square test, or Fisher exact test and log-rank test, while multivariate analysis was performed with Cox regression models adjusted for individual variables as well as a propensity score. RESULTS: A total of 934 patients were included in the study, with 27.5% of patients receiving surgery with postoperative radiation therapy (n = 257). In univariate analysis, there was no significant difference in 3-year overall survival between the patient groups ( P = .473). In multivariate analysis, there was no significant difference in survival between the treatment groups, with adjuvant radiation therapy having a hazard ratio of 0.93 (95% CI, 0.60-1.44; P = .748). Regarding tumors with a depth of invasion >5 mm, there was no survival benefit for the patients who received postoperative radiation therapy as compared with those who received surgery alone (hazard ratio = 0.93; 95% CI, 0.57-1.53; P = .769). CONCLUSION: An overall survival benefit was not demonstrated for patients who received postoperative radiation therapy versus surgery alone for pT2N0 oral cavity tongue cancer, irrespective of depth of tumor invasion.


Subject(s)
Glossectomy/methods , Margins of Excision , Tongue Neoplasms/mortality , Tongue Neoplasms/radiotherapy , Adult , Aged , Analysis of Variance , Cohort Studies , Disease-Free Survival , Female , Humans , Kaplan-Meier Estimate , Male , Middle Aged , Mouth Neoplasms/mortality , Mouth Neoplasms/pathology , Mouth Neoplasms/radiotherapy , Mouth Neoplasms/surgery , Neoplasm Invasiveness/pathology , Neoplasm Staging , Prognosis , Propensity Score , Proportional Hazards Models , Radiotherapy, Adjuvant , Retrospective Studies , SEER Program , Statistics, Nonparametric , Survival Analysis , Tongue Neoplasms/pathology , Tongue Neoplasms/surgery
14.
Laryngoscope ; 128(4): 831-840, 2018 04.
Article in English | MEDLINE | ID: mdl-28833217

ABSTRACT

OBJECTIVES/HYPOTHESIS: Randomized trials have demonstrated that adjuvant chemoradiotherapy (CRT) confers an overall survival (OS) benefit over adjuvant radiation therapy (RT) alone in patients with resected head and neck squamous cell carcinoma (HNSCC) with adverse pathologic features (positive surgical margins [SM+] and/or extracapsular extension [ECE]). Whether this OS benefit exists in an elderly population remains unknown. STUDY DESIGN: Retrospective database study. METHODS: Using the National Cancer Database, we identified 1,686 elderly patients (age ≥70 years) with resected HNSCC with SM+ and/or ECE, who received adjuvant CRT (491 patients, 29%) or adjuvant RT alone (1,195 patients, 71%) between 1998 and 2011. Three-year survival rates were estimated using the Kaplan-Meier method both before and after propensity score matching (PSM). Crude and adjusted hazard ratios (HR) with 95% confidence intervals (CI) were computed using Cox regression modeling. RESULTS: Median follow-up was 23.5 and 42.8 months for all and surviving patients, respectively. Three-year OS was 50.7% and 44.4% among patients receiving adjuvant CRT and RT alone, respectively (P = .002). On multivariate analysis, there was no significant improvement in OS with adjuvant CRT relative to adjuvant RT alone (HR: 0.88, 95% CI: 0.73-1.06). Similarly, a PSM cohort showed no significant difference in the 3-year OS for patients receiving adjuvant CRT versus adjuvant RT alone (48.8% and 50.9%, respectively; P = .839). CONCLUSIONS: Although the addition of chemotherapy to adjuvant RT has been proven effective in randomized trials of patients with resected HNSCC with SM+ or ECE, it may be less efficacious in an elderly patient population treated outside of a controlled trial setting. LEVEL OF EVIDENCE: 2c. Laryngoscope, 128:831-840, 2018.


Subject(s)
Carcinoma, Squamous Cell/mortality , Chemoradiotherapy, Adjuvant/mortality , Laryngeal Neoplasms/mortality , Laryngectomy/mortality , Salvage Therapy/mortality , Adult , Aged , Aged, 80 and over , Carcinoma, Squamous Cell/pathology , Carcinoma, Squamous Cell/therapy , Female , Humans , Laryngeal Neoplasms/pathology , Laryngeal Neoplasms/therapy , Laryngectomy/methods , Male , Margins of Excision , Middle Aged , Propensity Score , Proportional Hazards Models , Retrospective Studies , Salvage Therapy/methods , Survival Rate , Treatment Outcome
15.
Am J Otolaryngol ; 38(6): 654-659, 2017.
Article in English | MEDLINE | ID: mdl-28947344

ABSTRACT

PURPOSE: Determine whether marital status is a significant predictor of survival in human papillomavirus-positive oropharyngeal cancer. MATERIALS AND METHODS: A single center retrospective study included patients diagnosed with human papilloma virus-positive oropharyngeal cancer at Boston Medical Center between January 1, 2010 and December 30, 2015, and initiated treatment with curative intent at Boston Medical Center. Demographic data and tumor-related variables were recorded. Univariate analysis was performed using a two-sample t-test, chi-squared test, Fisher's exact test, and Kaplan Meier curves with a log rank test. Multivariate survival analysis was performed using a Cox regression model. RESULTS: A total of 65 patients were included in the study with 24 patients described as married and 41 patients described as single. There was no significant difference in most demographic variables or tumor related variables between the two study groups, except single patients were significantly more likely to have government insurance (p=0.0431). Furthermore, there was no significant difference in 3-year overall survival between married patients and single patients (married=91.67% vs single=87.80%; p=0.6532) or 3-year progression free survival (married=79.17% vs single=85.37%; p=0.8136). After adjusting for confounders including age, sex, race, insurance type, smoking status, treatment, and AJCC combined pathologic stage, marital status was not a significant predictor of survival [HR=0.903; 95% CI (0.126,6.489); p=0.9192]. CONCLUSIONS: Although previous literature has demonstrated that married patients with head and neck cancer have a survival benefit compared to single patients with head and neck cancer, we were unable to demonstrate the same survival benefit in a cohort of patients with human papilloma virus-positive oropharyngeal cancer.


Subject(s)
Carcinoma, Squamous Cell/mortality , Carcinoma, Squamous Cell/virology , Marital Status , Oropharyngeal Neoplasms/mortality , Oropharyngeal Neoplasms/virology , Papillomavirus Infections/mortality , Aged , Disease-Free Survival , Female , Humans , Kaplan-Meier Estimate , Male , Middle Aged , Papillomavirus Infections/pathology , Retrospective Studies , Survival Rate
17.
J Oral Maxillofac Surg ; 75(3): 449-457, 2017 Mar.
Article in English | MEDLINE | ID: mdl-27669370

ABSTRACT

PURPOSE: Shame is an ineffective tool in residency education that often results in depression, isolation, and worse patient care. This study aimed to assess burnout, depersonalization, and personal achievement levels in current oral and maxillofacial surgery (OMS) residents, to assess the prevalence of the use of shame in OMS residency training, and to determine whether there is a relation between shame exposure and resident burnout, depersonalization, and personal achievement levels. MATERIALS AND METHODS: An anonymous 20-question cross-sectional survey was developed incorporating the Maslach Burnout Index and a previously validated shame questionnaire and sent to all OMS program directors affiliated with the American Association of Oral and Maxillofacial Surgeons for distribution among their respective residents in 2016. Univariate analyses were used to determine the distribution of the predictor (shame) and outcome (burnout) by gender and by frequency of shaming events. Multivariable logistic regression analysis was used to assess the relation of shame to burnout. A 2-sided P value less than .05 was considered statistically significant. RESULTS: Two hundred seventeen responses were received; 82% of respondents were men (n = 178), 95% were 25 to 34 years old (n = 206), and 58% (n = 126) were enrolled in a 4-year program. Frequently shamed residents were more likely to have depression (58 vs 22%; P < .0001), isolation (55 vs 22%; P < .0001), and poor job performance (50 vs 30%; P < .0001). Residents who were frequently shamed were more likely to experience moderate to severe burnout (odds ratio = 4.6; 95% confidence interval, 2.1-10.0; P < .001) and severe depersonalization (odds ratio = 5.1; 95% confidence interval, 2.1-12.0; P < .0001) than residents who had never or infrequently been shamed. CONCLUSION: There is a clear relation between the number of shame events and burnout and depersonalization levels. It is important to understand the negative impact that the experience of shame has on residents, including its unintended consequences.


Subject(s)
Burnout, Professional/epidemiology , Depersonalization/epidemiology , Shame , Surgery, Oral/education , Adult , Education, Medical, Graduate , Female , Humans , Internship and Residency , Job Satisfaction , Male , Prevalence , Surveys and Questionnaires , United States/epidemiology
19.
Br J Oral Maxillofac Surg ; 50(8): 712-4, 2012 Dec.
Article in English | MEDLINE | ID: mdl-22444946

ABSTRACT

Minor intraoral tumours of the salivary glands are relatively uncommon. Most are histologically low grade and display no aggressive clinical features such as bony invasion or regional metastases. The aim of this study was to investigate retrospectively a bone-sparing approach to resection of low grade mucoepidermoid carcinoma of the hard palate in 18 patients. Only one had radiographic evidence of bony invasion and was treated by composite resection of the hard palate. Sixteen patients were treated by wide local excision with 1cm margins of soft tissue using the periosteum of the hard palate as the deep margin. The mean (SD) follow-up time was 44 months, (range 2-140). Among patients who had only soft tissue resection the histological margins were clear in 11 patients, and 5 had close or invaded margins that were all localised to the deep margin. There were no local recurrences during the follow-up period. We suggest that a bone-sparing approach to such tumours gives adequate local control, and composite resections should be reserved for tumours that have obviously invaded the hard palate.


Subject(s)
Carcinoma, Mucoepidermoid/surgery , Palate, Hard/surgery , Palate, Soft/surgery , Salivary Glands, Minor/surgery , Adolescent , Adult , Aged , Aged, 80 and over , Carcinoma, Mucoepidermoid/pathology , Female , Follow-Up Studies , Humans , Male , Middle Aged , Neoplasm Recurrence, Local/prevention & control , Palate, Hard/pathology , Palate, Soft/pathology , Retrospective Studies , Salivary Glands, Minor/pathology , Treatment Outcome
20.
Head Neck Pathol ; 5(4): 355-8, 2011 Dec.
Article in English | MEDLINE | ID: mdl-21805337

ABSTRACT

The aim of this study was to describe the clinical features of 18 cases of metastatic tumors to the oral cavity. The files of patients seen between 1992 and 2009 with oral (soft tissue and jawbones) metastatic lesions were reviewed. Clinical features, including gender, age, site of the primary tumor, site of metastatic tumor and treatment were evaluated. Patients were 11 males and 7 females, with mean age of 64.6 years. In males, most primary tumors originated in the lungs. In females, the lung and breast were the most common sites of the primary tumors. The mandible was the main site for the development of the metastatic lesions and the most common histologic type was adenocarcinoma. Treatment modalities included radiotherapy, chemotherapy and surgical resection. Metastatic lesions should be considered in the differential diagnosis of oral lesions, particularly when a previous history of cancer is present.


Subject(s)
Adenocarcinoma/diagnosis , Adenocarcinoma/secondary , Mouth Neoplasms/diagnosis , Mouth Neoplasms/secondary , Mouth/pathology , Adenocarcinoma/therapy , Aged , Aged, 80 and over , Breast Neoplasms/pathology , Combined Modality Therapy , Diagnosis, Differential , Drug Therapy , Female , Humans , Lung Neoplasms/pathology , Male , Middle Aged , Mouth Neoplasms/therapy , Oral Surgical Procedures , Radiotherapy , Retrospective Studies , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL
...